Search

ABSTRACT N‐Heterocyclic carbenes (NHCs) are molecules with exceptional catalytic properties in a wide range of reactions. Recently, there has been a growing interest in using them as catalysts for biomass conversion. In this review, we examine the current state of glycerol valorisation (GV) using several catalytic systems, including metallic complexes bearing NHCs as ligands, polymeric building blocks and organocatalysts. The study covers literature published in the last 15 years, detailing the catalyst scope, reaction conditions and products of GV. This analysis emphasises the importance of varying the steric and electronic properties of NHCs within the reviewed catalytic systems. Furthermore, a critical evaluation of the proposed mechanistic pathways complements these results. A comprehensive understanding of the challenges of using such catalytic systems will emerge by compiling literature on the use of NHCs for the studied reactions. Additionally, this will promote new opportunities for further research in both academic and industrial fields. [ABSTRACT FROM AUTHOR]

D‐Glyceraldehyde, a reactive aldehyde metabolite of fructose and glucose, is neurotoxic in vitro by forming advanced glycation end products (AGEs) with neuronal proteins. In Alzheimer's disease brains, glyceraldehyde‐containing AGEs have been detected intracellularly and in extracellular plaques. However, little information exists on how the brain handles D‐glyceraldehyde metabolically or if glyceraldehyde crosses the blood–brain barrier from the circulation into the brain. We injected [U‐13C]‐D‐glyceraldehyde intravenously into awake mice and analyzed extracts of serum and brain by 13C nuclear magnetic resonance spectroscopy. 13C‐Labeling of brain lactate and glutamate indicated passage of D‐glyceraldehyde from blood to brain and glycolytic and oxidative D‐glyceraldehyde metabolism in brain cells. 13C‐Labeling of serum glucose and lactate through hepatic metabolism of [U‐13C]‐D‐glyceraldehyde could not explain the formation of 13C‐labeled lactate and glutamate in the brain. Cerebral glyceraldehyde dehydrogenase and reductase activities, leading to the formation of D‐glycerate and glycerol, respectively, were 0.27–0.28 nmol/mg/min; triokinase, which phosphorylates D‐glyceraldehyde to D‐glyceraldehyde‐3‐phosphate, has been demonstrated previously at low levels. Thus, D‐glyceraldehyde metabolism toward glycolysis could proceed both through D‐glycerate, glycerol, and D‐glyceraldehyde‐3‐phosphate. The aldehyde group of D‐glyceraldehyde was overwhelmingly hydrated into a diol in aqueous solution, but the diol dehydration rate greatly exceeded glyceraldehyde metabolism and did not restrict it. We conclude that (1) D‐glyceraldehyde crosses the blood–brain barrier, and so blood‐borne glyceraldehyde could contribute to AGE formation in the brain, (2) glyceraldehyde is taken up and metabolized by brain cells. Metabolism thus constitutes a detoxification mechanism for this reactive aldehyde, a mechanism that may be compromised in disease states. [ABSTRACT FROM AUTHOR]

2-Keto-3-deoxy-galactonate (KDGal) serves as a pivotal metabolic intermediate within both the fungal d-galacturonate pathway, which is integral to pectin catabolism, and the bacterial DeLey-Doudoroff pathway for d-galactose catabolism. The presence of KDGal enantiomers, l-KDGal and d-KDGal, varies across these pathways. Fungal pathways generate l-KDGal through the reduction and dehydration of d-galacturonate, whereas bacterial pathways produce d-KDGal through the oxidation and dehydration of d-galactose. Two distinct catabolic routes further metabolize KDGal: a nonphosphorolytic pathway that employs aldolase and a phosphorolytic pathway involving kinase and aldolase. Recent findings have revealed that l-KDGal, identified in the bacterial catabolism of 3,6-anhydro-l-galactose, a major component of red seaweeds, is also catabolized by Escherichia coli, which is traditionally known to be catabolized by specific fungal species, such as Trichoderma reesei. Furthermore, the potential industrial applications of KDGal and its derivatives, such as pyruvate and d- and l-glyceraldehyde, are underscored by their significant biological functions. This review comprehensively outlines the catabolism of l-KDGal and d-KDGal across different biological systems, highlights stereospecific methods for discriminating between enantiomers, and explores industrial application prospects for producing KDGal enantiomers. Key points: • KDGal is a metabolic intermediate in fungal and bacterial pathways • Stereospecific enzymes can be used to identify the enantiomeric nature of KDGal • KDGal can be used to induce pectin catabolism or produce functional materials [ABSTRACT FROM AUTHOR]

Advanced glycation end-products (AGEs) form through non-enzymatic glycation of various proteins. Optic nerve degeneration is a frequent complication of diabetes, and retinal AGE accumulation is strongly linked to the development of diabetic retinopathy. Type 2 diabetes mellitus is a major risk factor for Alzheimer's disease (AD), with patients often exhibiting optic axon degeneration in the nerve fiber layer. Notably, a gap exists in our understanding of how AGEs contribute to neuronal degeneration in the optic nerve within the context of both diabetes and AD. Our previous work demonstrated that glyceraldehyde (GA)-derived toxic advanced glycation end-products (TAGE) disrupt neurite outgrowth through TAGE–β-tubulin aggregation and tau phosphorylation in neural cultures. In this study, we further illustrated GA-induced suppression of optic nerve axonal elongation via abnormal β-tubulin aggregation in mouse retinas. Elucidating this optic nerve degeneration mechanism holds promise for bridging the knowledge gap regarding vision loss associated with diabetes mellitus and AD. [ABSTRACT FROM AUTHOR]

Glycidol fatty acid esters that are present in foods are degraded in vivo to the animal carcinogen glycidol, which binds to the N‐terminal valine of hemoglobin (Hb) to form N‐(2,3‐dihydroxypropyl)valine (diHOPrVal) adducts. The existence of other chemicals that are converted to glycidol is unknown. To determine the effect of different exposure conditions on the formation of diHOPrVal adducts, several glycidol‐related chemicals (3‐monochloropropane‐1,2‐diol; 3‐MCPD, epichlorohydrin, glyceraldehyde, acrylic acid, and 1,2‐propanediol) were evaluated using in vitro and in vivo (single/repeated dose) methods. In vitro, the reaction of 3‐MCPD or epichlorohydrin with human Hb produced 17% and 0.7% of diHOPrVal, as compared to equimolar glycidol, respectively. Following a single administration of glycidol‐related compounds to ICR mice, diHOPrVal formation was observed only in the epichlorohydrin‐treated group after day 5 of exposure. After 14 days of repeated dosing, the amounts of diHOPrVal produced by epichlorohydrin and 3‐MCPD in vivo were <1% of diHOPrVal produced by an equal molar concentration of glycidol. Furthermore, glyceraldehyde group produced 0.2% of diHOPrVal at the same molar concentration of glycidol equivalents, in which diHOPrVal formation could not be confirmed by the in vitro assay. The results indicate the usefulness of diHOPrVal as an exposure marker for glycidol; however, the contribution of its formation in vivo by exposure to various chemicals will be necessary to validate and interpret the results. [ABSTRACT FROM AUTHOR]

Advanced glycation end-products (AGEs) form through non-enzymatic glycation of various proteins. Optic nerve degeneration is a frequent complication of diabetes, and retinal AGE accumulation is strongly linked to the development of diabetic retinopathy. Type 2 diabetes mellitus is a major risk factor for Alzheimer’s disease (AD), with patients often exhibiting optic axon degeneration in the nerve fiber layer. Notably, a gap exists in our understanding of how AGEs contribute to neuronal degeneration in the optic nerve within the context of both diabetes and AD. Our previous work demonstrated that glyceraldehyde (GA)-derived toxic advanced glycation end-products (TAGE) disrupt neurite outgrowth through TAGE–β-tubulin aggregation and tau phosphorylation in neural cultures. In this study, we further illustrated GA-induced suppression of optic nerve axonal elongation via abnormal β-tubulin aggregation in mouse retinas. Elucidating this optic nerve degeneration mechanism holds promise for bridging the knowledge gap regarding vision loss associated with diabetes mellitus and AD.

Different soft chemical syntheses were applied to synthesize eight Nb2O5 catalysts that were fully characterized in terms of structure, porosity, surface acidity and catalytic performance. The results showed that the catalysts indeed presented different structures and acidity. The distorted orthorhombic phase rendered solids with an improved porosity and allowed tuning higher concentrations of water-tolerant Lewis acid sites and higher Brønsted acidity when compared to a more crystalline pseudohexagonal phase. Catalysts holding the distorted orthorhombic structure were more active and selective to chemoconversion of trioses into lactic acid. It was shown though that product distribution was far more sensitive to changes in crystalline structure and Lewis acidity in the cascade reaction than the overall catalytic activity. A consistent linear correlation was found between lactic acid selectivity and the amount of water-tolerant Lewis acid sites, disclosing their dependence. It is the first time that such a clear correlation is demonstrated for triose upgrading cascade reaction. [ABSTRACT FROM AUTHOR]

The conversion of glycerol to high-value-added products via photoelectrochemical (PEC) oxidation has emerged as a promising approach for utilizing a sustainable and clean energy source with environmental and economic benefits. Moreover, the energy requirement for glycerol to produce hydrogen is lower than that for pure water splitting. In this study, we propose the use of WO3 nanostructures decorated with Bi-based metal–organic frameworks (Bi-MOFs) as the photoanode for glycerol oxidation with simultaneous hydrogen production. The WO3-based electrodes selectively converted glycerol to glyceraldehyde, a high-value-added product, with remarkable selectivity. The Bi-MOF-decorated WO3 nanorods enhanced the surface charge transfer and adsorption properties, thereby improving the photocurrent density and production rate (1.53 mA/cm2 and 257 mmol/m2·h at 0.8 VRHE). The photocurrent was maintained for 10 h, ensuring stable glycerol conversion. Furthermore, at 1.2 VRHE, the average production rate of glyceraldehyde reached 420 mmol/m2·h, with a selectivity of 93.6% between beneficial oxidized products over the photoelectrode. This study provides a practical approach for the conversion of glycerol to glyceraldehyde via the selective oxidation of WO3 nanostructures and demonstrates the potential of Bi-MOFs as a promising cocatalyst for PEC biomass valorization. [ABSTRACT FROM AUTHOR]

[Display omitted] • In-situ Raman tracking NiOx surface evolution, especially for the broadening band around 900 – 1200 cm-1. • Enhancing catalytic activity and selectivity of 3-carbon product through borate-polyol chelate. • Controlling five-member or six-member ring complex formation by varying borate/glycerol ratio. • Effect of borate/glycerol ratio on tuning selective oxidation of primary or secondary alcohol group. Controlling selective glycerol electrooxidation towards the primary or secondary alcohol group, which enables obtained dihydroxyacetone or glyceraldehyde as the main product, is a challenge for an effective glycerol electrolysis system. In this work, we systematically investigated the protective effect of borate-glycerol complexes toward primary and secondary alcohol group oxidation during the glycerol electrooxidation process on NiO x catalyst in borate buffer (pH 9.2). The Raman spectroscopy and high-performance liquid chromatography results indicated that manipulating the borate/glycerol (B/G) ratio could affect selective oxidation towards primary or secondary alcohol group. Five-member ring complex was more likely to form in the electrolyte with the B/G ratio of 0.1, whereas six-member ring complex became more significant in the electrolyte with the B/G ratio of 1.5. The dominance of five- or six-member ring complex could enhance the favored adsorption of primary or secondary alcohol group, thus generating glyceraldehyde or dihydroxyacetone as the main product, respectively. The results in this study highlight the significance of electrolyte property on glycerol electrocatalysis, which is universally applicable to other transition metal electrocatalysts, enabling the development of a highly selective glycerol electrooxidation towards primary or secondary alcohol system at near-neutral pH level. [ABSTRACT FROM AUTHOR]

[Display omitted] • Innovative FeOOH/BiVO 4 composite photoanode enhances glycerol conversion efficiency. • Electron-rich Bi-O-Fe active sites crucial for selective glyceraldehyde production. • Achieves a 14.98-fold increase in GLAD output compared to pristine BiVO 4. Heterojunction engineering is crucial for converting glycerol into valuable organic compounds via photoelectrochemistry, but controlling the structure precisely to enhance conversion efficiency remains challenging. In this study, we effectively created a compound photoanode with unique active regions by growing amorphous FeOOH co-catalysts on BiVO 4. The results revealed that the Fe2+ ions located on the surface of the co-catalyst FeOOH facilitate the glycerol transformation process, whereas the electron-rich Bi-O-Fe sites contribute significantly to the preferential transformation of glycerol into glyceraldehyde. These sites not only serve as primary reactive centers, catalyzing the adsorption and conversion of glycerol hydroxyl clusters, but also act as repositories for trapping holes. This dual function accelerates the breaking of C H bonds to generate glycerol aldehyde and exhibits excellent desorption capacity, ensuring exceptional product selectivity. This led to exceptional glyceraldehyde production (709mmol m-2 h−1) compared to pristine BiVO 4 , showcasing a 14.98-fold increase. [ABSTRACT FROM AUTHOR]

Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) induced by the dysfunction and cell death of cardiomyocytes. Cardiac fibroblasts are activated and differentiate in response to specific signals, such as transforming growth factor-β released from injured cardiomyocytes, and are crucial for the protection of cardiomyocytes, cardiac tissue repair, and remodeling. In contrast, cardiac fibroblasts have been shown to induce injury or death of cardiomyocytes and are implicated in the pathogenesis of diseases such as cardiac hypertrophy. We designated glyceraldehyde-derived advanced glycation end-products (AGEs) as toxic AGEs (TAGE) due to their cytotoxicity and association with LSRD. Intracellular TAGE in cardiomyocytes decreased their beating rate and induced cell death in the absence of myocardial ischemia. The TAGE levels in blood were elevated in patients with CVD and were associated with myocardial ischemia along with increased risk of atherosclerosis in vascular endothelial cells in vitro. The relationships between the dysfunction or cell death of cardiac fibroblasts and intracellular and extracellular TAGE, which are secreted from certain organs, remain unclear. We examined the cytotoxicity of intracellular TAGE by a slot blot analysis, and TAGE-modified bovine serum albumin (TAGE-BSA), a model of extracellular TAGE, in normal human cardiac fibroblasts (HCF). Intracellular TAGE induced cell death in normal HCF, whereas TAGE-BSA did not, even at aberrantly high non-physiological levels. Therefore, only intracellular TAGE induced cell death in HCF under physiological conditions, possibly inhibiting the role of HCF. [ABSTRACT FROM AUTHOR]

Diabetes mellitus (DM) has been identified as a risk factor for the onset and progression of Alzheimer's disease (AD). In our previous study, we demonstrated that glyceraldehyde (GA)-derived toxic advanced glycation end-products (toxic AGEs, TAGE) induced similar alterations to those observed in AD. GA induced dysfunctional neurite outgrowth via TAGE-β-tubulin aggregation, which resulted in the TAGE-dependent abnormal aggregation of β-tubulin and tau phosphorylation in human neuroblastoma SH-SY5Y cells. However, the effects of inhibitors of AGE formation on dysfunctional neurite outgrowth caused by GA-induced abnormalities in the aggregation of β-tubulin and tau phosphorylation remain unknown. Aminoguanidine (AG), an AGE inhibitor, and pyridoxamine (PM), a natural form of vitamin B6 (VB6), are effective AGE inhibitors. Therefore, the present study investigated whether AG or PM ameliorate TAGE-β-tubulin aggregation and the suppression of neurite outgrowth by GA. The results obtained showed that AG and PM inhibited the formation of TAGE-β-tubulin, mitigated the GA-induced suppression of neurite outgrowth, and reduced GA-mediated increases in tau phosphorylation levels. Collectively, these results suggest the potential of AG and PM to prevent the DM-associated onset and progression of AD. [ABSTRACT FROM AUTHOR]

Diabetes mellitus (DM) has been identified as a risk factor for the onset and progression of Alzheimer’s disease (AD). In our previous study, we demonstrated that glyceraldehyde (GA)-derived toxic advanced glycation end-products (toxic AGEs, TAGE) induced similar alterations to those observed in AD. GA induced dysfunctional neurite outgrowth via TAGE-β-tubulin aggregation, which resulted in the TAGE-dependent abnormal aggregation of β-tubulin and tau phosphorylation in human neuroblastoma SH-SY5Y cells. However, the effects of inhibitors of AGE formation on dysfunctional neurite outgrowth caused by GA-induced abnormalities in the aggregation of β-tubulin and tau phosphorylation remain unknown. Aminoguanidine (AG), an AGE inhibitor, and pyridoxamine (PM), a natural form of vitamin B6 (VB6), are effective AGE inhibitors. Therefore, the present study investigated whether AG or PM ameliorate TAGE-β-tubulin aggregation and the suppression of neurite outgrowth by GA. The results obtained showed that AG and PM inhibited the formation of TAGE-β-tubulin, mitigated the GA-induced suppression of neurite outgrowth, and reduced GA-mediated increases in tau phosphorylation levels. Collectively, these results suggest the potential of AG and PM to prevent the DM-associated onset and progression of AD.

The conversion of glycerol to high-value-added products via photoelectrochemical (PEC) oxidation has emerged as a promising approach for utilizing a sustainable and clean energy source with environmental and economic benefits. Moreover, the energy requirement for glycerol to produce hydrogen is lower than that for pure water splitting. In this study, we propose the use of WO3 nanostructures decorated with Bi-based metal–organic frameworks (Bi-MOFs) as the photoanode for glycerol oxidation with simultaneous hydrogen production. The WO3-based electrodes selectively converted glycerol to glyceraldehyde, a high-value-added product, with remarkable selectivity. The Bi-MOF-decorated WO3 nanorods enhanced the surface charge transfer and adsorption properties, thereby improving the photocurrent density and production rate (1.53 mA/cm2 and 257 mmol/m2·h at 0.8 VRHE). The photocurrent was maintained for 10 h, ensuring stable glycerol conversion. Furthermore, at 1.2 VRHE, the average production rate of glyceraldehyde reached 420 mmol/m2·h, with a selectivity of 93.6% between beneficial oxidized products over the photoelectrode. This study provides a practical approach for the conversion of glycerol to glyceraldehyde via the selective oxidation of WO3 nanostructures and demonstrates the potential of Bi-MOFs as a promising cocatalyst for PEC biomass valorization.

Abstract Background The habitual excessive intake of sugar (i.e., sucrose and high-fructose corn syrup), which has been implicated in the onset of diabetes mellitus, induces excessive production of glyceraldehyde, a metabolite produced during glucose and fructose metabolism, in hepatocytes, neuronal cells, and cardiomyocytes. Main text Toxic advanced glycation end-products (toxic AGEs, TAGE) are formed from reactions between glyceraldehyde and intracellular proteins, and their accumulation contributes to various cellular disorders. TAGE leakage from cells affects the surrounding cells and increases serum TAGE levels, promoting the onset and/or development of lifestyle-related diseases (LSRD). Therefore, serum TAGE levels have potential as a novel biomarker for predicting the onset and/or progression of LSRD, and minimizing the effects of TAGE might help to prevent the onset and/or progression of LSRD. Serum TAGE levels are closely related to LSRD associated with the excessive ingestion of sugar and/or dietary AGEs. Conclusions The TAGE theory is also expected to open new perspectives for research into numerous other diseases.

Abstract Background Sarcopenia is a progressive condition that is characterized by decreases in skeletal muscle mass and function. Although sarcopenia is associated with lifestyle-related diseases (LSRD), the mechanisms underlying cell death in myoblasts, which differentiate to myotubes, remain unclear. We previously designated glyceraldehyde (an intermediate of glucose/fructose metabolism)-derived advanced glycation end-products (AGEs) as toxic AGEs (TAGE) because of their cytotoxicity and involvement in LSRD, and hypothesized that TAGE contribute to cell death in myoblasts. Methods C2C12 cells, which are murine myoblasts, were treated with 0, 0.5, 1, 1.5, and 2 mM glyceraldehyde for 24 h. Cell viability and intracellular TAGE were then assessed using 5-[2,4,-bis(sodioxysulfonyl)phenyl]-3-(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl)-2H-tetrazole-3-ium (WST-8) and slot blot assays. Cells were pretreated with 8 mM aminoguanidine, an inhibitor of AGE production, for 2 h, followed by 0, 1.5, and 2 mM glyceraldehyde for 24 h. Cell viability and intracellular TAGE levels were then assessed. Serum TAGE levels in STAM mice, in which there were four stages (no steatosis, simple steatosis, steatohepatitis, and fibrosis), were measured using a competitive enzyme-linked immunosorbent assay. Results were expressed as TAGE units (U) per milliliter of serum, with 1 U corresponding to 1.0 μg of glyceraldehyde-derived AGE-bovine serum albumin (BSA) (TAGE-BSA). The viability of cells treated with 20, 50, and 100 μg/mL non-glycated BSA and TAGE-BSA for 24 h was assessed using the WST-8 assay. Results In C2C12 cells treated with 1.5 and 2 mM glyceraldehyde, cell viability decreased to 47.7% (p = 0.0021) and 5.0% (p = 0.0001) and intracellular TAGE levels increased to 6.0 and 15.9 μg/mg protein, respectively. Changes in cell viability and TAGE production were completely inhibited by 8 mM aminoguanidine. Serum TAGE levels at the steatohepatitis and fibrosis stages were 10.51 ± 1.16 and 10.44 ± 0.95 U/mL, respectively, and were higher than those at the no steatosis stage (7.27 ± 0.18 U/mL). Cell death was not induced by 20 or 50 μg/mL TAGE-BSA. The viabilities of C2C12 cells treated with 100 μg/mL non-glycated BSA and TAGE-BSA were 105.0% (p = 0.2890) and 85.3% (p = 0.0217), respectively. Conclusion Intracellular TAGE strongly induced cell death in C2C12 cells and may also induce myoblast cell death in LSRD model mice.

Advanced glycation end products (AGEs) are formed through the reaction/modification of proteins by saccharides (e.g., glucose and fructose) and their intermediate/non-enzymatic products [e.g., methylglyoxal and glyceraldehyde (GA)]. In 2017, Dr. Takanobu Takata et al. developed the novel slot blot method to quantify intracellular GA-derived AGEs (GA-AGEs). Although the original method required nitrocellulose membranes, we hypothesized that the modified proteins contained in the AGEs may be effectively probed on polyvinylidene difluoride (PVDF) membranes. Because commercial lysis buffers are unsuitable for this purpose, Dr. Takata developed the slot blot method using an in-house-prepared lysis buffer containing 2-amino-2-hydromethyl-1,3-propanediol (Tris), urea, thiourea, and 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS) that effectively probes AGEs onto PVDF membranes. The slot blot method also entails the calculation of Tris, urea, thiourea, and CHAPS concentrations, as well as protein and mass to be probed onto the PVDF membranes. GA-AGE-modified bovine serum albumin (BSA, GA-AGEs-BSA) is used to draw a standard curve and perform neutralization against a non-specific combination of anti-GA-AGEs antibodies, thereby enabling the quantification of GA-AGEs in cell lysates. This paper presents the detailed protocol for slot blot analysis of intracellular GA-AGE levels in C2C12 cells. Key features • This protocol leverages the idea that advanced glycation end products are modified proteins. • The lysis buffer containing Tris, urea, thiourea, and CHAPS enables probing proteins onto PVDF membranes. • Intracellular GA-AGE levels may be quantified for some cell types using polyclonal anti-GA-AGE antibodies and standard GA-AGE-modified BSA. • The lysis buffer may be simultaneously prepared with the cell lysate. • There is no limit to the type of cultured cells used in the preparation of cell lysate., Competing Interests: Competing interestsThe authors declare no competing interests., (©Copyright : © 2024 The Authors; This is an open access article under the CC BY-NC license.)

Reducing sugars and reactive aldehydes, such as glyceraldehyde, non-enzymatically react with amino or guanidino groups of proteins to form advanced glycation end-products (AGEs) by the Maillard reaction that involves Schiff base formation followed by Amadori rearrangement. AGEs are found relatively in abundance in the human eye and to accumulate at a higher rate in diseases that impair vision such as cataract, diabetic retinopathy or age-related macular degeneration. We identified two novel AGEs of pyrrolopyridinium lysine dimer derived from glyceraldehyde, PPG1 and PPG2, in the Maillard reaction of Nα-acetyl-l-lysine with glyceraldehyde under physiological conditions. Having fluorophores similar to that of vesperlysine A, which was isolated from the human lens, PPGs were found to act as photosensitizers producing singlet oxygen in response to blue light irradiation. Moreover, PPG2 interacts with receptor for AGE (RAGE) in vitro with a higher binding affinity than GLAP, a well-known ligand of the receptor. We also proposed a pathway to form PPGs and discussed how they would be formed in vitro. As glyceraldehyde-derived AGEs have been studied extensively in connection with various hyperglycemia-related diseases, further studies will be required to find PPGs in vivo such as in the lens or other tissues.

Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) induced by the dysfunction and cell death of cardiomyocytes. Cardiac fibroblasts are activated and differentiate in response to specific signals, such as transforming growth factor-β released from injured cardiomyocytes, and are crucial for the protection of cardiomyocytes, cardiac tissue repair, and remodeling. In contrast, cardiac fibroblasts have been shown to induce injury or death of cardiomyocytes and are implicated in the pathogenesis of diseases such as cardiac hypertrophy. We designated glyceraldehyde-derived advanced glycation end-products (AGEs) as toxic AGEs (TAGE) due to their cytotoxicity and association with LSRD. Intracellular TAGE in cardiomyocytes decreased their beating rate and induced cell death in the absence of myocardial ischemia. The TAGE levels in blood were elevated in patients with CVD and were associated with myocardial ischemia along with increased risk of atherosclerosis in vascular endothelial cells in vitro. The relationships between the dysfunction or cell death of cardiac fibroblasts and intracellular and extracellular TAGE, which are secreted from certain organs, remain unclear. We examined the cytotoxicity of intracellular TAGE by a slot blot analysis, and TAGE-modified bovine serum albumin (TAGE-BSA), a model of extracellular TAGE, in normal human cardiac fibroblasts (HCF). Intracellular TAGE induced cell death in normal HCF, whereas TAGE-BSA did not, even at aberrantly high non-physiological levels. Therefore, only intracellular TAGE induced cell death in HCF under physiological conditions, possibly inhibiting the role of HCF.

The glycerol oxidation reaction (GLYOR) was evaluated using an Au/C electrocatalyst under alkaline conditions and varying glycerol (GLY) concentration. This electrocatalyst was synthesized by the borohydride reduction method. Au/C was characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), and electrochemical techniques associated with in situ attenuated total reflectance Fourier transformed infrared spectroscopy (ATR-FTIR). XRD diffractograms showed the presence of Au (fcc). Cyclic voltammetry assisted by ATR-FTIR in situ measurements revealed that GLY oxidation on gold leads to the formation of a high amount of glyceraldehyde (GLYAD) for low GLY concentrations, while a lower amount of GLYAD was observed and the formation of dihydroxyacetone (DHA) was prevalent for high GLY concentrations. For high GLY concentrations DHA is almost stable, whereas for low GLY concentration DHA is fast oxidized to hydroxypyruvate. The excellent GLYOR activity of the Au/C catalyst in low GLY concentrations leads to the formation of deeper oxidized C1 species. • Gliceraldehyde production is favored at lower glycerol concentrations. • Water plays a significant role in lowering the activation energy of glyceraldehyde. • Electrochemical route to production of Dihydroxyacetone. [ABSTRACT FROM AUTHOR]

In this work, fluorinated and platinized TiO2 were evaluated in the glycerol oxidation. Fluorination led to increasing the specific surface area of titania, and platinization treatment to obtaining the highest absorption in the visible region of the electromagnetic spectrum; thus, 0.5 wt% Pt-F-TiO2 was the best catalyst for its highest yield and good selectivity to glyceraldehyde (GAL). It was also found that 2 wt% of Pt content had a detrimental effect on the glycerol conversion. Fluorination and platinum addition led to modify the reaction mechanism and selectivity. [ABSTRACT FROM AUTHOR]

AKR1B10 is an aldose reductase (AR) homologue overexpressed in liver cancer and various forms of that enzyme in carcinomas catalyze the reduction of anticancer drugs, potential cytostatic drug, and dl-glyceraldehyde but do not catalyze the reduction of glucose. Kinetic parameters for wild-type and C299S mutant AKR1B10 indicate that substitution of serine for cysteine at position 299 reduces the affinity of this protein for dl-glyceraldehyde and enhances its catalytic activity. Fibrates suppress peroxisome proliferation and the development of liver cancer in human. Here we report the potency of fibrate-mediated inhibition of the carbonyl reduction catalyzed by wild-type and C299S mutant AKR1B10 and compare it with known AR inhibitors. Wild-type AKR1B10-catalyzed carbonyl reduction follows pure non-competitive inhibition kinetics using zopolrestat, EBPC or sorbinil, whereas fenofibrate, Wy 14,643, ciprofibrate and fenofibric acid follow mixed non-competitive inhibition kinetics. In contrast, catalysis of reaction by the C299S AKR1B10 mutant is not inhibited by sorbinil and EBPC. Despite these differences, the C299S AKR1B10 mutant still manifests kinetics similar to the wild-type protein with other fibrates including zopolrestat, fenofibrate, Wy 14,346, gemfibrozil and ciprofibrate that show mixed non-competitive inhibition kinetics. The reaction of the mutant AKR1B10 is inhibited by fenofibric acid, but manifests pure non-competitive inhibition kinetics that are different from those demonstrated for the wild-type enzyme.

The rheological changes that occur during the chemical gelation of semidilute solutions of chitosan in the presence of the low-toxicity agent glyceraldehyde (GCA) are presented and discussed in detail. The entanglement concentration for chitosan solutions was found to be approximately 0.2 wt.% and the rheological experiments were carried out on 1 wt.% chitosan solutions with various amounts of GCA at different temperatures (25 °C and 40 °C) and pH values (4.8 and 5.8). High crosslinker concentration, as well as elevated temperature and pH close to the pKa value (pH ≈ 6.3–7) of chitosan are three parameters that all accelerate the gelation process. These conditions also promote a faster solid-like response of the gel-network in the post-gel region after long curing times. The mesh size of the gel-network after a very long (18 h) curing time was found to contract with increasing level of crosslinker addition and elevated temperature. The gelation of chitosan in the presence of other chemical crosslinker agents (glutaraldehyde and genipin) is discussed and a comparison with GCA is made. Small angle neutron scattering (SANS) results reveal structural changes between chitosan solutions, incipient gels, and mature gels.

Glycerol valorization through partial oxidation is a good way of obtaining many different molecules with high added value such as glyceric acid, tartronic acid, dihydroxyacetone, etc. Among the potential products, glyceraldehyde is an interesting chemical compound for its various applications in different domains such as organic chemistry, medical, and cosmetic industries. In the present paper, we studied the effect of different supports on the glycerol oxidation reaction in a batch reactor applying base-free conditions. The tested catalysts were Pt-based materials deposited on various supports (i.e., SiO2, TiO2, ZSM-5, γ-Al2O3), which were synthesized using a deposition method followed by a chemical reduction. The catalysts were extensively characterized (BET, ICP, XRD, TEM, XPS), highlighting differences in terms of specific surface areas, textural properties, and Pt nanoparticles sizes. We evidenced a direct relation between glycerol conversion and glyceraldehyde selectivity (i.e., an increase in glycerol conversion leads to a decrease in glyceraldehyde selectivity). The Pt/γ-Al2O3 catalysts exhibited the highest activity, but their selectivity to glyceraldehyde significantly decreased with time on stream. Pt/SiO2 presented the highest selectivity to glyceraldehyde owing to a slower reaction rate, which allows envisioning technical opportunities to continuously extract the formed glyceraldehyde from the mixture.

Advanced glycation end-products (AGEs), formed through glyceraldehyde (GA) as an intermediate in non-enzymatic reactions with intracellular proteins, are cytotoxic and have been implicated in the pathogenesis of various diseases. Despite their significance, the mechanisms underlying the degradation of GA-derived AGEs (GA-AGEs) remain unclear. In the present study, we found that N-terminal checkpoint kinase 1 cleavage products (CHK1-CPs) and their mimic protein, d270WT, were degraded intracellularly post-GA exposure. Notably, a kinase-dead d270WT variant (d270KD) underwent rapid GA-induced degradation, primarily via the ubiquitin-proteasome pathway. The high-molecular-weight complexes formed by the GA stimulation of d270KD were abundant in the RIPA-insoluble fraction, which also contained high levels of GA-AGEs. Immunoprecipitation experiments indicated that the high-molecular-weight complexes of d270KD were modified by GA-AGEs and that p62/SQSTM1 was one of its components. The knockdown of p62 or treatment with chloroquine reduced the amount of high-molecular-weight complexes in the RIPA-insoluble fraction, indicating its involvement in the formation of GA-AGE aggregates. The present results suggest that the ubiquitin-proteasome pathway and p62 play a role in the degradation and aggregation of intracellular GA-AGEs. This study provides novel insights into the mechanisms underlying GA-AGE metabolism and may lead to the development of novel therapeutic strategies for diseases associated with the accumulation of GA-AGEs.

Glyceraldehyde-derived advanced glycation end products (AGEs) play an important role in the pathogenesis of many diseases including cancer. Accumulation of intracellular AGEs could stimulate cancer induction and facilitate cancer progression. We evaluated the toxic effect of glyceraldehyde-derived intracellular AGEs on normal and malignant pancreatic ductal cells by assessing the cell viability, toxicity, and oxidative stress, followed by proteomic analysis. Our functional studies showed that pancreatic cancer cells (PANC-1 and MIA PaCa-2) were more resistant to glyceraldehyde treatment compared to normal pancreatic ductal epithelial cells (HPDE), while cytotoxicity effects were observed in all cell types. Furthermore, using 13C isotopic labeled glyceraldehyde, the proteomic data revealed a dose-dependent increment of the number of glycation adducts in both these cell types. HPDE cells showed a higher number of intracellular AGEs compared to cancer cells. At a molecular level, the glycations in the lysine residues of proteins showed a concurrent increase with the concentration of the glyceraldehyde treatment, while the arginine glycations appeared to be less affected by the glyceraldehyde doses. Further pathway analysis of these glycated proteins suggested that the glycated proteins participate in important biological processes that are major hallmarks of cancer initiation and progression, including metabolic processes, immune response, oxidative stress, apoptosis, and S100 protein binding.

Aqueous‐phase conversion of glyceraldehyde to lactic acid was investigated over Nb2O5, TiO2, ZrO2 and SnO2 in a fixed‐bed up‐flow reactor. Special attention was given to the catalysts acidity regarding the type, amount, strength and tolerance to water of surface acid sites. These sites were assessed by infrared spectroscopy of pyridine adsorbed on dehydrated and hydrated catalysts as well as by isopropanol decomposition. It was found that Nb2O5 and TiO2 have the highest fraction of water‐tolerant Lewis acid sites (40 and 47 %), while only 6 % was estimated for ZrO2. No relevant Lewis acidity was observed on SnO2, but it was noticed the presence of strong base sites. The transformation of glyceraldehyde into lactic acid proceeded via a cascade reaction in which glyceraldehyde is firstly dehydrated to pyruvaldehyde, followed by its rearrangement to lactic acid with the addition of a water molecule. The dehydration step occurs on Brønsted acid sites and/or on water‐tolerant Lewis acid sites. These latter sites also determine the selectivity to lactic acid. Strong base sites promote glyceraldehyde fragmentation leading to formaldehyde with high selectivity. [ABSTRACT FROM AUTHOR]

Abstract: CuNiAl hydrotalcites supported BiOCl were prepared by one-step synthesis for the selective oxidation of glycerol to glyceraldehyde with H2O2 as oxidant. The prepared catalysts were found to be efficient due to the synergetic catalysis of surface oxygen vacancies, active Cu2+ ions in the HT-lattice and abundant surface -OH groups of catalysts. The optimal glycerol conversion could reach 75.4% with 82.4% of the selectivity to glyceraldehyde. Moreover, the catalyst could be reused at least 6 times, and a possible reaction mechanism was also proposed.Graphical Abstract: Inexpensive and environmentally friendly BiOCl/CuNiAl-HTs were synthesized by one-step for the highly selective oxidation of glycerol to glyceraldehyde. The glycerol conversion could reach 75.4% with 82.4% selectivity to GLAD. Such a highly efficient catalytic performance could be attributed to the synergistic effect of oxygen vacancies and the coordination of glycerol on Bi3+ in the supported BiOCl catalyst. [ABSTRACT FROM AUTHOR]

Background: This study aims to assess the efficacy of the scleral collagen cross-linking method using glyceraldehyde solution for prevention of lens-induced axial elongation in New Zealand rabbits and investigate the biochemical and microstructural changes that occur. Methods: The right eyes of New Zealand rabbits aged seven weeks were randomly divided into three groups: the cross-linking group (n = 6), non-crosslinking group (n = 5), and untreated control group (n = 5). Eyes in cross-linking and non-crosslinking groups were treated with a −8.00 Diopter spherical lens over the course of two weeks. The cross-linking effects were achieved by a sub-Tenon's injection of 0.15 ml 0.5 M glyceraldehyde to eyes in the CL group. Ocular parameters were measured on the 1st, 7th, and 14th days. Biomechanical testing, light and electronic microscopy were used. Results: Following the cross-linking treatment, eyes in the cross-linking group had a shorter axial length compared to those in the non-crosslinking group (p = 0.006). Collagen fibrils larger than 240 nm were observed in the scleral stroma of cross-linking group, which were absent in the scleral stroma of the non-crosslinking and untreated control group. The mean ultimate stress and Young's modulus was significantly greater in the cross-linking group compared to those in the non-crosslinking and untreated control group (p < 0.05). No histological damage observed in the retina or choroid. Conclusions: This study demonstrates that lens-induced axial elongation in rabbits can be effectively blocked by cross-linking using glyceraldehyde, with anatomical and mechanical modification and no deleterious effects. [ABSTRACT FROM AUTHOR]

Acetaldehyde is a physiological species existing in blood. Glyceraldehyde is a commonly used surrogate for glucose in studies of nonenzymatic glycation. Both species exist in dynamic equilibrium between two forms, an aldehyde and a hydrate. Nonenzymatic covalent protein modification (NECPM) is a process whereby a protein is covalently modified by a non-glucose species. The purpose here was to elucidate the NECPM mechanism(s) for acetaldehyde and glyceraldehyde with human hemoglobin (HbA). For the first time, both aldehydic and hydrate forms of acetaldehyde and glyceraldehyde were considered. Computations and model reactions followed by 1H NMR were employed. Results demonstrated that the aldehyde and hydrate forms of acetaldehyde bind and covalently-modify Val1 of HbA via different chemical mechanisms, yet generated an identical protonated Schiff base (PSB). The aldehyde and hydrate of glyceraldehyde also covalently modified Val1 via mechanisms distinct from one another, yet generated an identical PSB. It is noteworthy that the PSB from acetaldehyde and glyceraldehyde were different structures. The PSB from acetaldehyde is proposed to proceed to covalent adducts that have been implicated in alcohol toxicity. Conversely, the PSB generated from glyceraldehyde can form an Amadori which has been implicated in diabetic complications. Thus, the PSB structure generated from acetaldehyde versus glyceraldehyde may be central to pathophysiological outcomes because it determines the structure of the stable covalent adduct formed. [ABSTRACT FROM AUTHOR]